INVESTORS & MEDIA
Investor Relations
Market Cap:
Dec 2, 2022 3:18 PM EST
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Quarterly Materials
We are a leading science and technology company that delivers life-transforming medicines for serious diseases.
Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.
Interactive Analyst Center
Interactive and downloadable financial data for investors and analysts
